[A new contrast medium emulsion for lymphography (author's transl)]. 1979

S L Roth, and H Dombrowski, and U Hiort, and H Kalbfleisch, and K Ludwig, and F Siefart, and A Seher, and E Vielhauer

A new contrast medium for lymphography has been developed. It is suitable for direct, such as bi-pedal, lymphangiography, and has certain advantages compared with the commercially available contrast medium Ethiodol, such as absence of a lipogranulomatous reaction and less extensive oil emboli in the lungs. It is also possible to use the substance for indirect, retrosternal lymphography. The substance is indirect, retrosternal lymphography. The substance is an emulsion of triglycerides of iodinated poppy seed oil. The method of preparation of the emulsion is described.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008220 Lymphography Radiographic study of the lymphatic system following injection of dye or contrast medium. Lymphangiography,Lymphangiographies,Lymphographies
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug

Related Publications

S L Roth, and H Dombrowski, and U Hiort, and H Kalbfleisch, and K Ludwig, and F Siefart, and A Seher, and E Vielhauer
April 1970, Die Pharmazie,
S L Roth, and H Dombrowski, and U Hiort, and H Kalbfleisch, and K Ludwig, and F Siefart, and A Seher, and E Vielhauer
September 1975, Der Radiologe,
S L Roth, and H Dombrowski, and U Hiort, and H Kalbfleisch, and K Ludwig, and F Siefart, and A Seher, and E Vielhauer
March 1976, Rontgen-Blatter; Zeitschrift fur Rontgen-Technik und medizinisch-wissenschaftliche Photographie,
S L Roth, and H Dombrowski, and U Hiort, and H Kalbfleisch, and K Ludwig, and F Siefart, and A Seher, and E Vielhauer
January 1980, Polski przeglad radiologii i medycyny nuklearnej,
S L Roth, and H Dombrowski, and U Hiort, and H Kalbfleisch, and K Ludwig, and F Siefart, and A Seher, and E Vielhauer
October 1976, Der Radiologe,
S L Roth, and H Dombrowski, and U Hiort, and H Kalbfleisch, and K Ludwig, and F Siefart, and A Seher, and E Vielhauer
December 1980, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
S L Roth, and H Dombrowski, and U Hiort, and H Kalbfleisch, and K Ludwig, and F Siefart, and A Seher, and E Vielhauer
July 1975, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
S L Roth, and H Dombrowski, and U Hiort, and H Kalbfleisch, and K Ludwig, and F Siefart, and A Seher, and E Vielhauer
December 1981, La Radiologia medica,
S L Roth, and H Dombrowski, and U Hiort, and H Kalbfleisch, and K Ludwig, and F Siefart, and A Seher, and E Vielhauer
January 1962, Rassegna medica sarda,
S L Roth, and H Dombrowski, and U Hiort, and H Kalbfleisch, and K Ludwig, and F Siefart, and A Seher, and E Vielhauer
February 1969, Wiener medizinische Wochenschrift (1946),
Copied contents to your clipboard!